INS and metabolic dysfunction-associated steatohepatitis: Furthermore, acetate treatment significantly decreased hepatic TG levels, serum ALT, and AST levels (Figure S7A), and hepatic lipid droplet accumulation (Figure S7B), while improving glucose tolerance and insulin sensitivity (Figure S7C-E), indicating a protective effect against NASH-associated lipid dysregulation.